Medtronic’s Q1 2022 results, J&J CEO to step down & more: 4 device company notes

Medtronic’s 23 percent increase in quarterly revenue and three more updates from spine and orthopedic device companies in the last week:

Advertisement

1. Medtronic posted its financial results for the first quarter of fiscal year 2022 on Aug. 24. Read more here.

2. Shoulder Innovation’s InSet reverse shoulder arthroplasty system received FDA 510(k) clearance.

3. Alex Gorsky will step down as chair and CEO of Johnson & Johnson and serve as executive chairman effective Jan. 3, 2022.

4. Here are eight things to know about Joaquin Duato, who will succeed Mr. Gorsky as Johnson & Johnson’s CEO.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.